WallStSmart
OCS

Oculis Holding AG Ordinary shares

NASDAQ: OCS · HEALTHCARE · BIOTECHNOLOGY

$27.48
+3.89% today

Updated 2026-04-30

Market cap
$1.57B
P/E ratio
P/S ratio
1,311.54x
EPS (TTM)
$-2.40
Dividend yield
52W range
$16 – $31
Volume
0.4M

WallStSmart proprietary scores

29
out of 100
Grade: F
Strong Sell
Investment rating
6.3
Growth
B
6.8
Quality
B
2.5
Profitability
F
5.0
Valuation
C+
1/9
Piotroski F-Score
Weak
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target
$47.50
+72.85%
12-Month target
Intrinsic (DCF)
Margin of safety
3 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 13,600.00% QoQ
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-16.02M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$912000.00$883000.00$686000.00$0.00$1.20M
Net income$-38.70M$-88.80M$-85.78M$-94.51M$-23.34M
EPS$-2.40
Free cash flow$-28.62M$-53.89M$-47.73M$-62.51M$-16.02M
Profit margin-4,243.20%-10,056.85%-12,503.94%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
OCS$1.57B296.32.55.06.8Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Oculis Holding AG Ordinary shares trades at $27.48. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. TTM revenue stands at $1.20M.

Frequently asked questions

What is Oculis Holding AG Ordinary shares's stock price?
Oculis Holding AG Ordinary shares (OCS) trades at $27.48.
Is Oculis Holding AG Ordinary shares overvalued?
Smart Value Score 29/100 (Grade F, Strong Sell).
What is the price target of Oculis Holding AG Ordinary shares (OCS)?
The analyst target price is $47.50, representing +72.9% upside from the current price of $27.48.
What is Oculis Holding AG Ordinary shares's revenue?
TTM revenue is $1.20M.
Piotroski F-Score?
1/9 — weak financial health.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio1,311.54x
ROE-73.50%
Beta0.21
50D MA$27.18
200D MA$21.94
Shares out0.06B
Float0.05B
Short ratio
Avg volume0.4M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years